Table 1 Patient characteristics in data cohorts
Overall | Training set | Paired validation set | Temporal validation set | ||||||
---|---|---|---|---|---|---|---|---|---|
Variable | MSI-H, N = 138a | MSS, N = 5400a | p-valueb | MSI-H, N = 73a | MSS, N = 3942a | MSI-H, N = 34a | MSS, N = 139a | MSI-H, N = 31a | MSS, N = 1319a |
Age at collection date | 71 (65, 76) | 66 (60, 73) | <0.001 | 71 (64, 76) | 66 (60, 72) | 71 (65, 76) | 68 (61, 73) | 69 (63, 77) | 68 (61, 74) |
Unknown | 14 | 892 | – | 6 | 524 | 1 | 16 | 7 | 352 |
Race | 0.5 | ||||||||
Asian (%) | 3 (4.2) | 67 (2.7) | – | 1 (2.9) | 56 (2.9) | 1 (4.8) | 1 (1.3) | 1 (6.7) | 10 (2.0) |
Black or African American (%) | 11 (15) | 472 (19) | – | 2 (5.7) | 355 (19) | 4 (19) | 11 (15) | 5 (33) | 106 (21) |
White (%) | 57 (80) | 1942 (78) | – | 32 (91) | 1494 (78) | 16 (76) | 63 (84) | 9 (60) | 385 (77) |
Unknown | 67 | 2919 | – | 38 | 2037 | 13 | 64 | 16 | 818 |
Histology | 0.6 | ||||||||
Adenocarcinoma (%) | 136 (99) | 5315 (98) | – | 71 (97) | 3874 (98) | 34 (100) | 135 (97) | 31 (100) | 1306 (99) |
Carcinoma (%) | 1 (0.7) | 17 (0.3) | – | 1 (1.4) | 15 (0.4) | 0 (0) | 1 (0.7) | 0 (0) | 1 (<0.1) |
Neuroendocrine (%) | 1 (0.7) | 51 (0.9) | – | 1 (1.4) | 40 (1.0) | 0 (0) | 1 (0.7) | 0 (0) | 10 (0.8) |
Sarcoma (%) | 0 (0) | 3 (<0.1) | – | 0 (0) | 3 (<0.1) | – | – | – | – |
Small cell carcinoma (%) | 0 (0) | 14 (0.3) | – | 0 (0) | 10 (0.3) | 0 (0) | 2 (1.4) | 0 (0) | 2 (0.2) |
Total gleason | <0.001 | ||||||||
7 (%) | 5 (4.3) | 878 (21) | – | 3 (4.8) | 692 (22) | 0 (0) | 9 (8.1) | 2 (8.7) | 177 (20) |
8 (%) | 18 (15) | 832 (20) | – | 9 (15) | 617 (20) | 3 (9.4) | 11 (9.9) | 6 (26) | 204 (22) |
9 (%) | 61 (52) | 2097 (50) | – | 33 (53) | 1605 (51) | 17 (53) | 51 (46) | 11 (48) | 441 (49) |
10 (%) | 33 (28) | 370 (8.9) | – | 17 (27) | 245 (7.8) | 12 (38) | 40 (36) | 4 (17) | 85 (9.4) |
Unknown | 21 | 1223 | – | 11 | 783 | 2 | 28 | 8 | 412 |
Procedure type | 0.5 | ||||||||
Ambiguous biopsy (%) | 18 (13) | 578 (11) | – | 11 (15) | 431 (12) | 3 (9.1) | 12 (8.9) | 4 (13) | 135 (10) |
Core needle biopsy (%) | 80 (59) | 2910 (56) | – | 42 (58) | 2009 (54) | 18 (55) | 77 (57) | 20 (65) | 824 (63) |
Resection + excisional (%) | 38 (28) | 1691 (33) | – | 19 (26) | 1293 (35) | 12 (36) | 46 (34) | 7 (23) | 352 (27) |
Unknown | 2 | 221 | – | 1 | 209 | 1 | 4 | 0 | 8 |